Immunome
(NASDAQ) IMNM
Immunome Financials at a Glance
Market Cap
$2.64BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$4.02M
Net Income (TTM)
-$224.59M
EPS (TTM)
-$2.38
P/E Ratio
-9.81
Dividend
$0.00
Beta (Volatility)
1.52 (High)
Dividend
$0.00
Beta (Volatility)
1.52 (High)
Price
$23.42
Volume
34,607
Open
$24.12
Price
$23.42
Volume
34,607
Open
$24.12
Previous Close
$23.42
Daily Range
$22.31 - $24.12
52-Week Range
$7.96 - $27.65
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
1.52 (High)
Price
$23.42
Volume
34,607
Open
$24.12
Previous Close
$23.42
Daily Range
$22.31 - $24.12
52-Week Range
$7.96 - $27.65
Estimated Earnings Date
Aug 5, 2026
IMNM News
IMNM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Immunome
Industry
Biotechnology
Sector
Health CareEmployees
177
CEO
Clay B. Siegall, PhD
Website
www.immunome.comHeadquarters
Bothell, WA 98011, US
IMNM Financials
Key Financial Metrics (TTM)
Gross Margin
-1161.92%
Operating Margin
-5947.90%
Net Income Margin
-5593.85%
Return on Equity
-51.15%
Return on Capital
-33.55%
Return on Assets
-36.24%
Earnings Yield
-10.19%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.64BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
113.25M
Volume
34.61K
Avg. Volume
1.32M
Financials (TTM)
Gross Profit
-$46.65M
Operating Income
-$238.81M
EBITDA
-$221.76M
Operating Cash Flow
-$196.50M
Capital Expenditure
-$9.02M
Free Cash Flow
-$205.52M
Cash & ST Invst.
$582.69M
Total Debt
$3.69M
Immunome Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
-$753.00K
-125.7%
Gross Margin
0.00%
N/A
Market Cap
$2.64BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$14.94M
N/A
Employees
177
N/A
Net Income
-$53.84M
-29.3%
EBITDA
-$53.09M
-29.8%
Quarterly Fundamentals
Total Cash
$582.69M
+83.6%
Total Debt
$3.69M
-22.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$3.69M
-22.6%
Short Term Debt
$0.00
N/A
Return on Assets
-36.24%
N/A
Return on Invested Capital
-40.31%
N/A
Free Cash Flow
-$61.64M
-8.7%
Operating Cash Flow
-$58.64M
-10.5%